Spain Non-alcoholic Steatohepatitis Biomarkers Market Size & Outlook
Spain non-alcoholic steatohepatitis biomarkers market, 2018-2030 (US$M)
Related Markets
Spain non-alcoholic steatohepatitis biomarkers market highlights
- The Spain non-alcoholic steatohepatitis biomarkers market generated a revenue of USD 14.5 million in 2021 and is expected to reach USD 87.6 million by 2030.
- The Spain market is expected to grow at a CAGR of 22.2% from 2022 to 2030.
- In terms of segment, serum biomarkers was the largest revenue generating type in 2021.
- Hepatic Fibrosis Biomarkers is the most lucrative type segment registering the fastest growth during the forecast period.
Non-alcoholic steatohepatitis biomarkers market data book summary
| Market revenue in 2021 | USD 14.5 million |
| Market revenue in 2030 | USD 87.6 million |
| Growth rate | 22.2% (CAGR from 2021 to 2030) |
| Largest segment | Serum biomarkers |
| Fastest growing segment | Hepatic Fibrosis Biomarkers |
| Historical data | 2018 - 2020 |
| Base year | 2021 |
| Forecast period | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Serum Biomarkers, Hepatic Fibrosis Biomarkers, Apoptosis Biomarkers, Oxidative Stress Biomarkers |
| Key market players worldwide | Genfit SA, Siemens AG, Quest Diagnostics Inc, AstraZeneca PLC, Meridian Bioscience, Labcorp Holdings Inc, Pfizer Inc, Bristol-Myers Squibb Co |
Other key industry trends
- In terms of revenue, Spain accounted for 1.7% of the global non-alcoholic steatohepatitis biomarkers market in 2021.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany non-alcoholic steatohepatitis biomarkers market is projected to lead the regional market in terms of revenue in 2030.
- France is the fastest growing regional market in Europe and is projected to reach USD 164.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Non-alcoholic Steatohepatitis Biomarkers Market Scope
Non-alcoholic Steatohepatitis Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Spain non-alcoholic steatohepatitis biomarkers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-alcoholic steatohepatitis biomarkers market will help companies and investors design strategic landscapes.
Serum biomarkers was the largest segment with a revenue share of 33.1% in 2021. Horizon Databook has segmented the Spain non-alcoholic steatohepatitis biomarkers market based on serum biomarkers, hepatic fibrosis biomarkers, apoptosis biomarkers, oxidative stress biomarkers covering the revenue growth of each sub-segment from 2018 to 2030.
The market is driven by rising incidence of diabetes and obesity. According to International Diabetes Federation, 5,141,300 total cases of diabetes are reported in 2022. Around 21.6% of the adult population is suffering from obesity in Spain.
Moreover, the burden of NASH in the country is increasing R&D activities to develop diagnostics tests at an early stage. According to an article, around 2.0% of the general population is estimated to be affected with NASH, and 1.3% of the population has treatable NASH fibrosis.
In addition, economic development is likely to have a positive impact on affordability and consequent market penetration of biomarkers. Early & accurate diagnosis and timely treatment would aid in reducing disease burden and mortality rate.
Reasons to subscribe to Spain non-alcoholic steatohepatitis biomarkers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Spain non-alcoholic steatohepatitis biomarkers market databook
-
Our clientele includes a mix of non-alcoholic steatohepatitis biomarkers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain non-alcoholic steatohepatitis biomarkers market , including forecasts for subscribers. This country databook contains high-level insights into Spain non-alcoholic steatohepatitis biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Spain non-alcoholic steatohepatitis biomarkers market size, by type, 2018-2030 (US$M)
Spain Non-alcoholic Steatohepatitis Biomarkers Market Outlook Share, 2021 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
